PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

A method to predict Alzheimer's disease within 2 years of screening

2013-12-02
(Press-News.org) Contact information: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-343-7593
University of Montreal
A method to predict Alzheimer's disease within 2 years of screening This news release is available in French.

At the first signs of memory loss, most people start worrying and wonder, "What if I have Alzheimer's disease?" And yet, the disease is often diagnosed late in its development and sometimes up to ten years after the first pathological changes have affected the brain. A major goal in the treatment of Alzheimer's disease has been to provide earlier diagnosis so that patients can receive treatment as early as possible. A study by Sylvie Belleville, PhD, Director of Research at the Institut universitaire de gériatrie de Montréal, an institution affiliated with Université de Montréal, has shown a way to do just that. In their study, Sylvie Belleville and her team accurately predicted (at a rate of 90%) which of their research subjects with mild cognitive impairment would receive a clinical diagnosis of Alzheimer's disease within the following two years and which subjects would not develop this disease. The study was published in Volume 38, Issue 2 of the prestigious Journal of Alzheimer's Disease.

By combining brain imaging analysis with a neuropsychological assessment, Sylvie Belleville achieved remarkable sensitivity (targeting the people who will develop the disease) and specificity (eliminating false positives, that is those who would remain stable). The level of accuracy of this classification system is the major breakthrough of the study. "When used individually, neuroimaging and neuropsychology are effective but only up to a certain point. It is when combining and analyzing the results from both methods that we could achieve such an exceptional level of accuracy," explained Sylvie Belleville.

Major benefits for Alzheimer's patients and for research

"For the moment, we can't diagnose this disease very early due to the lack of reliable protocols. Thus, there is a risk of erronously identifying the disease when trying to diagnose it too early. Identifying markers that correctly predict the subsequent onset of more severe symptoms that are sensitive and specific considerably reduces the uncertainty of early diagnosis. The innovation here is showing that two different approaches can be combined to aid in diagnosis," said Sylvie Belleville.

Researchers who work on Alzheimer's disease can build on this advance to go even further. "The clinical benefits of these extra two years are enormous. We can now evaluate the effectiveness of pharmacological and non-pharmacological therapies on the outcome of a clinical diagnosis of Alzheimer's disease in people identified with these tools. We could assess whether these treatments are more effective when administered earlier. The questions we now need to answer are whether pharmacological treatment started at the onset of early warning signs will slow the illness and whether brain plasticity could be stimulated in a more structured way to delay symptoms that cause disability."

Research summary The objective of this work was to examine the potential benefit of combining two classes of measures for the detection of incipient dementia in individuals with mild cognitive impairment (MCI). Baseline measures included MRI measures of hippocampal volume, cortical thickness and white matter hyperintensities as well as different measures of episodic memory and executive control functions. The study identified the measures that best predicted which MCI patients would progress to dementia compared to those who remained stable. The strongest neuroimaging predictors were baseline cortical thickness in the right anterior cingulate and middle frontal gyri. For cognitive predictors, we found that deficits in both free recall and recognition episodic memory tasks were highly suggestive of progression to dementia. Cortical thinning in the right anterior cingulate gyrus, combined to controlled and familiarity-based retrieval deficits, achieved a classification accuracy of 87.5%, a specificity of 90.9% and a sensitivity of 83.3%. This predictive model including both classes of measures provided more accurate predictions than those based on neuroimaging or cognitive measures alone.

### About the author Sylvie Belleville, PhD, is the Director of Research at the Institut universitaire de gériatrie de Montréal and a full professor in the Department of Psychology at Université de Montréal.


ELSE PRESS RELEASES FROM THIS DATE:

Increased risk for cardiac ischemia in patients with PTSD

2013-12-02
Increased risk for cardiac ischemia in patients with PTSD Reports a new study in Biological Psychiatry Philadelphia, PA, December 2, 2013 – There is growing concern that long-term untreated posttraumatic stress disorder (PTSD) symptoms may increase the risk of developing ...

US mothers from 1965 to 2010: more TV, less housework

2013-12-02
US mothers from 1965 to 2010: more TV, less housework New research from the University of South Carolina's Arnold School of Public Health shows that mothers in the U.S. are far less physically active than they were in previous decades and now spend more ...

Goals affect feelings of pride and shame after success and failure

2013-12-02
Goals affect feelings of pride and shame after success and failure When the St. Louis Cardinals lost the World Series, just how much shame did the players feel? According to researchers at Penn State and Australia's Central Queensland University, a person's goals at the outset of ...

When aluminum outshines gold

2013-12-02
When aluminum outshines gold 2 Rice University studies detail aluminum's valuable plasmonic properties HOUSTON – (Dec. 2, 2013) – Humble aluminum's plasmonic properties may make it far more valuable than gold and silver for certain applications, according to new research by ...

Colon cancer researchers target stem cells, discover viable new therapeutic path

2013-12-02
Colon cancer researchers target stem cells, discover viable new therapeutic path (TORONTO, Canada – Dec. 1, 2013) - Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming ...

'Nanosponge vaccine' fights MRSA toxins

2013-12-02
'Nanosponge vaccine' fights MRSA toxins Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled ...

The mystery of neutron stars heats up

2013-12-02
The mystery of neutron stars heats up Until now, scientists were pretty sure they knew how the surface of a neutron star – a super dense star that forms when a large star explodes and its core collapses into itself – can heat itself up. However, research by ...

Human stem cells converted to functional lung cells

2013-12-02
Human stem cells converted to functional lung cells Possibility of generating lung tissue for transplant using a patient's own cells NEW YORK, NY — For the first time, scientists have succeeded in transforming human stem cells into functional ...

Imaging shows long-term impact of blast-induced brain injuries in veterans

2013-12-02
Imaging shows long-term impact of blast-induced brain injuries in veterans CHICAGO – Using a special type of magnetic resonance imaging (MRI), researchers have found that soldiers who suffered mild traumatic brain injury (MTBI) induced by blast exposure ...

Cardiac MRI reveals energy drinks alter heart function

2013-12-02
Cardiac MRI reveals energy drinks alter heart function CHICAGO – Healthy adults who consumed energy drinks high in caffeine and taurine had significantly increased heart contraction rates one hour later, according to a study presented today at the ...

LAST 30 PRESS RELEASES:

Sylvester Cancer Tip Sheet for October 2025

Three science and technology leaders elected to Hertz Foundation Board of Directors

Jump Trading CSO Kevin Bowers elected to Hertz Foundation Board of Directors

Former Inscripta CEO Sri Kosaraju elected to Hertz Foundation Board of Directors

Citadel’s Jordan Chetty elected to Hertz Foundation Board of Directors

McGill research flags Montreal snow dump, inactive landfills as major methane polluters

A lightweight and rapid bidirectional search algorithm

Eighty-five years of big tree history available in one place for the first time

MIT invents human brain model with six major cell types to enable personalized disease research, drug discovery

Health and economic air quality co-benefits of stringent climate policies

How immune cells deliver their deadly cargo

How the brain becomes a better listener: How focus enhances sound processing

Processed fats found in margarines unlikely to affect heart health

Scientists discover how leukemia cells evade treatment

Sandra Shi MD, MPH, named 2025 STAT Wunderkind

Treating liver disease with microscopic nanoparticles

Chemicals might be hitching a ride on nanoplastics to enter your skin

Pregnant patients with preexisting high cholesterol may have elevated CV risk

UC stroke experts discuss current and future use of AI tools in research and treatment

The Southern Ocean’s low-salinity water locked away CO2 for decades, but...

OHSU researchers develop functional eggs from human skin cells

Most users cannot identify AI bias, even in training data

Hurricane outages: Analysis details the where, and who, of increased future power cuts

Craters on surface of melanoma cells found to serve as sites for tumor killing

Research Spotlight: Mapping overlooked challenges in stroke recovery

Geographic and temporal patterns of screening for breast, cervical, and colorectal cancer in the US

Cannabis laws and opioid use among commercially insured patients with cancer diagnoses

Research Spotlight: Surprising gene mutation in brain’s immune cells linked to increased Alzheimer’s risk

Missing molecule may explain Down syndrome

Donor diabetes and 1-year Descemet membrane endothelial keratoplasty success rate

[Press-News.org] A method to predict Alzheimer's disease within 2 years of screening